The impact of the codelivery of drug-siRNA by trimethyl chitosan nanoparticles on the efficacy of chemotherapy for metastatic breast cancer cell line (MDA-MB-231)

References

• Anbazhagan R, Bartek J, Monaghan P, Gusterson B. 1991. Growth and development of the human infant breast. Am J Anat. 192:407–417.
   PubMedGoogle Scholar
• Atyabi F, Majzoob S, Iman M, Salehi M, Dorkoosh F. 2005. In vitro evaluation and modification of pectinate gel beads containing trimethyl chitosan, as a multi-particulate system for delivery of water-soluble macromolecules to colon. Carbohyd Polym. 61:39–51.
   Web of Science ®Google Scholar
• Bullions LC, Levine AJ. 1998. The role of beta-catenin in cell adhesion, signal transduction, and cancer. Curr Opin Oncol. 10:81–87.
   PubMedGoogle Scholar
• Chaffer CL, Brennan JP, Slavin JL, Blick T, Thompson EW, Williams ED. 2006. Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2. Cancer Res. 66:11271–11278.
   PubMed Web of Science ®Google Scholar
• Christofori G, Semb H. 1999. The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem Sci. 24:73–76.
   PubMed Web of Science ®Google Scholar
• Di Cello F, Hillion J, Hristov A, Wood LJ, Mukherjee M, Schuldenfrei A, et al. 2008. HMGA2 participates in transformation in human lung cancer. Mol. Cancer Res. 6:743–750.
   PubMed Web of Science ®Google Scholar
• Fusco A, Fedele M. 2007. Roles of HMGA proteins in cancer. Nat Rev Cancer. 7:899–910.
   PubMed Web of Science ®Google Scholar
• Gao D, Vahdat LT, Wong S, Chang JC, Mittal V. 2012. Microenvironmental regulation of epithelial–mesenchymal transitions in cancer. Cancer Res. 72:4883–4889.
   PubMed Web of Science ®Google Scholar
• Hammond SM, Sharpless NE. 2008. HMGA2, microRNAs, and stem cell aging. Cell. 135:1013–1016.
   PubMed Web of Science ®Google Scholar
• Howard KA, Rahbek UL, Liu X, Damgaard CK, Glud SZ, Andersen MØ, et al. 2006. RNA interference in vitro and in vivo using a chitosan/siRNA nanoparticle system. Mol Ther. 14:476–484.
   PubMed Web of Science ®Google Scholar
• Janes K, Calvo P, Alonso M. 2001. Polysaccharide colloidal particles as delivery systems for macromolecules. Adv Drug Deliv Rev. 47:83–97.
   PubMed Web of Science ®Google Scholar
• Jenuwein T. 2006. The epigenetic magic of histone lysine methylation. FEBS J. 273:3121–3135.
   PubMed Web of Science ®Google Scholar
• John A, Tuszynski G. 2001. The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol Oncol Res. 7:14–23.
   PubMedGoogle Scholar
• Kamaly N, Xiao Z, Valencia PM, Radovic-Moreno AF, Farokhzad OC. 2012. Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. Chem Soc Rev. 41:2971–3010.
   PubMed Web of Science ®Google Scholar
• Kesse-Adu R, Shousha S. 2004. Myoepithelial markers are expressed in at least 29% of oestrogen receptor negative invasive breast carcinoma. Mod Pathol. 17:646–652.
   PubMed Web of Science ®Google Scholar
• Kotzé AR, Lueβen HL, De Leeuw BJ, Verhoef JC, Junginger HE. 1997. N-trimethyl chitosan chloride as a potential absorption enhancer across mucosal surfaces: in vitro evaluation in intestinal epithelial cells (Caco-2). Pharm Res. 14:1197–1202.
   PubMed Web of Science ®Google Scholar
• Kouzarides T. 2002. Histone methylation in transcriptional control. Curr Opin Genet Dev. 12:198–209.
   PubMed Web of Science ®Google Scholar
• Kumar MS, Armenteros-Monterroso E, East P, Chakravorty P, Matthews N, Winslow MM, Downward J. 2014. HMGA2 functions as a competing endogenous RNA to promote lung cancer progression. Nature. 505:212–217.
   PubMed Web of Science ®Google Scholar
• La Rocca G, Pucci-Minafra I, Marrazzo A, Taormina P, Minafra S. 2004. Zymographic detection and clinical correlations of MMP-2 and MMP-9 in breast cancer sera. Br J Cancer. 90:1414–1421.
   PubMed Web of Science ®Google Scholar
• Leppä S, Saarto T, Vehmanen L, Blomqvist C, Elomaa I. 2004. A high serum matrix metalloproteinase-2 level is associated with an adverse prognosis in node-positive breast carcinoma. Clin Cancer Res. 10:1057–1063.
   PubMed Web of Science ®Google Scholar
• Lim J, Thiery JP. 2012. Epithelial-mesenchymal transitions: insights from development. Development. 139:3471–3486.
   PubMed Web of Science ®Google Scholar
• Liu AN, Zhu ZH, Chang SJ, Hang XS. 2012. Twist expression associated with the epithelial-mesenchymal transition in gastric cancer. Mol Cell Biochem. 367:195–203.
   PubMed Web of Science ®Google Scholar
• Mahajan A, Liu Z, Gellert L, Zou X, Yang G, Lee P, Yang X, Wei JJ. 2010. HMGA2: a biomarker significantly overexpressed in high-grade ovarian serous carcinoma. Mod Pathol. 23:673–681.
   PubMed Web of Science ®Google Scholar
• Mao S, Sun W, Kissel T. 2010. Chitosan-based formulations for delivery of DNA and siRNA. Adv Drug Deliv Rev. 62:12–27.
   PubMed Web of Science ®Google Scholar
• Meiners S, Brinkmann V, Naundorf H, Birchmeier W. 1998. Role of morphogenetic factors in metastasis of mammary carcinoma cells. Oncogene. 16:9–20.
   PubMed Web of Science ®Google Scholar
• Mittnacht U, Hartmann H, Hein S, Oliveira H, Dong MP, Peêgo A, et al. 2010. Chitosan/siRNA nanoparticles biofunctionalize nerve implants and enable neurite outgrowth. Nano Lett. 10:3933–3939.
   PubMed Web of Science ®Google Scholar
• Mousavi S, Alamolhoda A, Gouya M, Lickiss N. 2008. Implementation of comprehensive national cancer control program in Iran: an experience in a developing country. Ann Oncol. 19:398–400.
   PubMed Web of Science ®Google Scholar
• Nguyen M, Arkell J, Jackson CJ. 2001. Human endothelial gelatinases and angiogenesis. Int J Biochem Cell Biol. 33:960–970.
   PubMed Web of Science ®Google Scholar
• Noori-Daloii MR, Momeny M, Yousefi M, Shirazi FG, Yaseri M, Motamed N, Kazemialiakbar N, Hashemi S. 2011. Multifaceted preventive effects of single agent quercetin on a human prostate adenocarcinoma cell line (PC-3): implications for nutritional transcriptomics and multi-target therapy. Med Oncol. 28:1395–1404.
   PubMed Web of Science ®Google Scholar
• Perl AK, Wilgenbus P, Dahl U, Semb H, Christofori G. 1998. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature. 392:190–193.
   PubMed Web of Science ®Google Scholar
• Saad M, Garbuzenko O, Minko T. 2008. Co-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancer. Nanomedicine (London, England). 3:761–76
   Google Scholar
• Savagner P. 2001. Leaving the neighborhood: molecular mechanisms involved during epithelial‐mesenchymal transition. Bioessays. 23:912–923.
   PubMed Web of Science ®Google Scholar
• Smith A, Teknos TN, Pan Q. 2013. Epithelial to mesenchymal transition in head and neck squamous cell carcinoma. Oral Oncol. 49:287–292.
   PubMed Web of Science ®Google Scholar
• Stetler-Stevenson WG. 1999. Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention. J Clin Invest. 103:1237.
   PubMed Web of Science ®Google Scholar
• Thiery JP. 2002. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer. 2:442–454.
   PubMed Web of Science ®Google Scholar
• Todosi AM, Gavrilescu MM, Aniţei GM, Filip B, Scripcariu V. 2012. Colon cancer at molecular level-usefulness of epithelial-mesenchymal transition analysis.
   Google Scholar
• Tsukada K, Matsumoto T, Aizawa K, Tokoro A, Naruse RS, Suzuki S, Suzuki M. 1990. Antimetastatic and growth-inhibitory effects of N-acetylchitohexaose in mice bearing Lewis lung carcinoma. Jpn J Cancer Res. 81:259–265.
   PubMedGoogle Scholar
• Ueno H, Murakami M, Okumura M, Kadosawa T, Uede T, Fujinaga T. 2001. Chitosan accelerates the production of osteopontin from polymorphonuclear leukocytes. Biomaterials. 22:1667–1673.
   PubMed Web of Science ®Google Scholar
• Vashist SK, Zheng D, Pastorin G, Al-Rubeaan K, Luong JH, Sheu FS. 2011. Delivery of drugs and biomolecules using carbon nanotubes. Carbon. 49:4077–4097.
   Web of Science ®Google Scholar
• Villalta PC, Rocic P, Townsley MI. 2014. Role of MMP2 and MMP9 in TRPV4-induced lung injury. Am J Physiol Lung Cell Mol Physiol. 307:L652–L659.
   PubMed Web of Science ®Google Scholar
• Xia YY, Yin L, Tian H, Guo WJ, Jiang N, Jiang XS, et al. 2015. hMga2 is associated with epithelial–mesenchymal transition and can predict poor prognosis in nasopharyngeal carcinoma. Onco Targets Ther. 8:169.
   PubMed Web of Science ®Google Scholar
• Yang G, Zhang L, Bo J, Hou K, Cai X, Chen Y, et al. 2011. Overexpression of HMGA2 in bladder cancer and its association with clinicopathologic features and prognosis: HMGA2 as a prognostic marker of bladder cancer. Eur J Surg Oncol. 37:265–271.
   PubMed Web of Science ®Google Scholar
• Yin L, Ding J, He C, Cui L, Tang C, Yin C. 2009. Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery. Biomaterials. 30:5691–5700.
   PubMed Web of Science ®Google Scholar